By Connor Hart
Shares of Avita Medical gained after the company said it received an approval from the Food and Drug Administration for its system to treat smaller wounds.
The stock was up 6.4%, to $12.50, in after-hours trading Monday. Shares--which ended the regular session about flat, at $11.75--are down 14% since the beginning of the year.
The medical-device maker said its system, the Recell Go mini, is designed to treat wounds up to 480 square centimeters. It is a line extension of the Recall Go system, which treats an area of 1,920 square centimeters.
Roll out of the system will begin during the first quarter of 2025, the company said.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
December 23, 2024 17:48 ET (22:48 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.